Development of a tumor targeting method using artificial intelligence/augmented reality for precise tumor resection in breast cancer patients and verification of safety and accuracy through clinical applicatio
- Conditions
- Neoplasms
- Registration Number
- KCT0006634
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- Female
- Target Recruitment
- 50
* Female patients from 20 to 79 years of ages
* Female patients who are scheduled to have breast-conserving surgery
* Subjects who fully understands and agrees in writing to the informed consent form
a. Patients scheduled for total mastectomy
b. Patients who have contraindications of MRI
- Those with an inserted electrical device, clip for the prevention of aneurysm, artificial of metallic material around the eyeball
- Patients who have Claustrophobia
- Patients with difficulty using gadolinium-based angiography - severe allergic or impaired of kidney function ( creatinine > 2.0)
- Pregnant
c. Difficult partial resection due to large calcification lesions
d. Patients deemed unsuitable to participate in this clinical trial at the Investigator's discretion
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Consistency between tumor-marked areas by conventional method and tumor-marked area by AR method
- Secondary Outcome Measures
Name Time Method Tumor invasion status of resection margin;Distance from resection margin to tumor